Raloxifene is an oral selective estrogen receptor modulator, marketed by Eli Lilly under the name Evista. It aids in the prevention and treatment of osteoporosis.
API's & Drug Standards
Bone Disease & Osteoporosis
|Formula||C28H27NO4S · HCI|
|Appearance||Off-white to pale yellow powde|
|Storage Conditions||Room temperature|
Send us your enquiry for Raloxifene Hydrochloride. We offer custom pack sizes at special prices. We aim to respond to your enquiry within 24 hours.
We value your input so if you have suggestions regarding new applications for Raloxifene Hydrochloride email us and we will include your contribution on the website.